The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms
Abstract
Endothelial dysfunction contributes to cardiovascular diseases, including hypertension, atherosclerosis, and coronary artery disease, which are also characterized by insulin resistance. Insulin resistance is a hallmark of metabolic disorders, including type 2 diabetes mellitus and obesity, which are also characterized by endothelial dysfunction. Metabolic actions of insulin to promote glucose disposal are augmented by vascular actions of insulin in endothelium to stimulate production of the vasodilator nitric oxide (NO). Indeed, NO-dependent increases in blood flow to skeletal muscle account for 25% to 40% of the increase in glucose uptake in response to insulin stimulation. Phosphatidylinositol 3-kinase-dependent insulin-signaling pathways in endothelium related to production of NO share striking similarities with metabolic pathways in skeletal muscle that promote glucose uptake. Other distinct nonmetabolic branches of insulin-signaling pathways regulate secretion of the vasoconstrictor endothelin-1 in endothelium. Metabolic insulin resistance is characterized by pathway-specific impairment in phosphatidylinositol 3-kinase-dependent signaling, which in endothelium may cause imbalance between production of NO and secretion of endothelin-1, leading to decreased blood flow, which worsens insulin resistance. Therapeutic interventions in animal models and human studies have demonstrated that improving endothelial function ameliorates insulin resistance, whereas improving insulin sensitivity ameliorates endothelial dysfunction. Taken together, cellular, physiological, clinical, and epidemiological studies strongly support a reciprocal relationship between endothelial dysfunction and insulin resistance that helps to link cardiovascular and metabolic diseases. In the present review, we discuss pathophysiological mechanisms, including inflammatory processes, that couple endothelial dysfunction with insulin resistance and emphasize important therapeutic implications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial dysfunction is attributed to many causes, including oxidative stress, chronic inflammation, and endothelium activation, in diabetes, which exhibits excessive free fatty acid (FFA), insulin resistance, and/or hyperglycemia [216,217].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [217]
In the citing paper
“The insulin receptor shares a signaling pathway with the activation of endothelial NOS (eNOS) [19,48,49,50,51,52] to regulate the postprandial blood flow and efficient nutrient disposition to peripheral tissues”
From NO-Rich Diet for Lifestyle-Related Diseases (2015) · cites this paper as [50]
In the citing paper
“insulin resistance is always associated with impaired NO availability, suggesting that a reciprocal relationship exists between insulin activation and endothelial function [50,53].”
From NO-Rich Diet for Lifestyle-Related Diseases (2015) · cites this paper as [50]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Flagged first, then by citations
Research works printed but not linked: 15
- 10.1161/circ.101.13.1539 · DOI
- Formoso G Chen H Kim J Montagnani M Consoli A Quon MJ. DHEA mimics acute actions of insulin to stimulate production of both NO and ET-1 via distinct PI 3-kinase- and MAP-kinase-dependent pathways in vascular endothelium. Mol Endocrinol. In press.
- 10.1161/circ.100.8.820 · DOI
- 10.1161/hyp.34.4.586 · DOI
- Renkin EM. Control of microcirculation and blood-tissue exchange. In: Handbook of Physiology: The Cardiovascular System: Microcirculation. Bethesda Md: American Physiological Society; 1984: 627–687.
- 10.1161/circ.103.21.2531 · DOI
- 10.1161/circ.102.18.2165 · DOI
- 10.1161/circ.101.6.676 · DOI
- 10.1161/hyp.35.6.1270 · DOI
- 10.1161/circ.100.15.1646 · DOI
- 10.1161/circ.102.11.1296 · DOI
- 10.1161/hyp.26.2.290 · DOI
- Potenza MA, Marasciulo FL, Tarquinio M, Quon MJ, Montagnani M. Rosiglitazone improves hypertension in spontaneously hypertensive rats (SHR) by decreasing endothelial MAP kinase signaling and endothelin-1 (ET-1) secretion. Diabetes. 2005; 54 (suppl 1): A320. Abstract.
- 10.1161/atvb.21.12.1891 · DOI
- 10.1161/atvb.20.6.1595 · DOI
Cited by
Sorted by citations
Items 201–300 of 999
Role of Heme in Cardiovascular Physiology and Disease
Sawicki, K. T., Chang, H., & Ardehali, H. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001138 · Cited by 112
Role of Insulin Resistance and Hyperglycemia in the Development of Atherosclerosis
Bansilal, S., Farkouh, M. E., & Fuster, V. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.002 · Cited by 113
Antiatherosclerotic and Anti-Insulin Resistance Effects of Adiponectin: Basic and Clinical Studies
Han, S. H., Sakuma, I., Shin, E. K., & Koh, K. K. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.06.004 · Cited by 115
Wang, D., Uhrín, P., Mocan, A., Waltenberger, B., Breuss, J. M., Tewari, D., Mihaly‐Bison, J., Huminiecki, Ł., Starzyński, R. R., Tzvetkov, N. T., et al. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.04.006 · Cited by 111
Fernandez-Twinn, D. S., Gascoin, G., Musial, B., Carr, S., Duque-Guimaraes, D., Blackmore, H. L., Alfaradhi, M. Z., Loche, E., Sferruzzi-Perri, A. N., Fowden, A. L., et al. (2017) · Scientific Reports · doi:10.1038/srep44650 · Cited by 115
Lipotoxicity contributes to endothelial dysfunction: A focus on the contribution from ceramide
Symons, J. D., & Abel, E. D. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9235-3 · Cited by 112
Azimzadeh, O., Sievert, W., Sarioglu, H., Merl‐Pham, J., Yentrapalli, R., Bakshi, M. V., Janik, D., Ueffing, M., Atkinson, M. J., Multhoff, G., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr501141b · Cited by 112
Gogg, S., Smith, U., & Jansson, P. (2009) · Diabetes · doi:10.2337/db08-0961 · Cited by 112
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes
Fadini, G. P., de Kreutzenberg, S., Agostini, C., Boscaro, E., Tiengo, A., Dimmeler, S., & Avogaro, A. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.040 · Cited by 110
Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation
Saito, T., Hasegawa, Y., Ishigaki, Y., Yamada, T., Gao, J., Imai, J., Uno, K., Kaneko, K., Ogihara, T., Shimosawa, T., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs298 · Cited by 108
Ding, H., Aljofan, M., & Triggle, C. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21063 · Cited by 107
Pullikotil, P., Chen, H., Muniyappa, R., Greenberg, C. C., Yang, S., Reiter, C. E. N., Lee, J.-W., Chung, J. H., & Quon, M. J. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.06.007 · Cited by 106
Liu, Z., Liu, J., Jahn, L. A., Fowler, D. E., & Barrett, E. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0027 · Cited by 107
Alshnbari, A. S., Millar, S., O’Sullivan, S. E., & IDRIS, I. R. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00885-z · Cited by 109
Iantorno, M., Chen, H., Kim, J., Tesauro, M., Lauro, D., Cardillo, C., & Quon, M. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00570.2006 · Cited by 107
Galán, M., Kassan, M., Choi, S. K., Partyka, M., Trebak, M., Henrion, D., & Matrougui, K. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.192500 · Cited by 105
Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders
El‐Hattab, A. W., Emrick, L., Craigen, W. J., & Scaglia, F. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.06.018 · Cited by 106
Chow, E. J., Simmons, J. H., Roth, C. L., Baker, K. S., Hoffmeister, P. A., Sanders, J. E., & Friedman, D. L. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.05.016 · Cited by 104
Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes
Panigrahy, S. K., Bhatt, R., & Kumar, A. (2017) · Journal of Drug Targeting · doi:10.1080/1061186x.2016.1207650 · Cited by 103
Hypertension in Metabolic Syndrome: Vascular Pathophysiology
Mendizábal, Y., Llorens, S., & Nava, E. (2013) · International Journal of Hypertension · doi:10.1155/2013/230868 · Cited by 107
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression
Wang, N., & Zhang, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063086 · Cited by 116
Reiter, C. E. N., Kim, J., & Quon, M. J. (2009) · Endocrinology · doi:10.1210/en.2009-0997 · Cited by 100
Effects of an intravenous endotoxin challenge on glucose and insulin dynamics in horses
Tóth, F., Frank, N., Elliott, S. B., Geor, R. J., & Boston, R. C. (2008) · American Journal of Veterinary Research · doi:10.2460/ajvr.69.1.82 · Cited by 101
Park, E., Edirisinghe, I., Choy, Y. Y., Waterhouse, A. L., & Burton‐Freeman, B. M. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515004328 · Cited by 102
Munir, K. M., Chandrasekaran, S., Gao, F., & Quon, M. J. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00377.2013 · Cited by 103
Protein kinase C in enhanced vascular tone in diabetes mellitus
Kizub, I. V., Klymenko, K., & Soloviev, A. I. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.117 · Cited by 104
Chocolate, Lifestyle, and Health
Visioli, F., Bernaert, H., Corti, R., Ferri, C., Heptinstall, S., Molinari, E., Poli, A., Serafini, M., Smit, H. J., Vinson, J. A., et al. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802066805 · Cited by 99
Obesity, blood vessels and metabolic syndrome
Tesauro, M., & Cardillo, C. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02290.x · Cited by 98
Maternal high-fat diet impacts endothelial function in nonhuman primate offspring
Fan, L., Lindsley, S. R., Comstock, S. M., Takahashi, D. L., Evans, A. E., He, G.-W., Thornburg, K. L., & Grove, K. L. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.42 · Cited by 98
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects
Salvatore, T., Pafundi, P. C., Galiero, R., Rinaldi, L., Caturano, A., Vetrano, E., Aprea, C., Albanese, G., Di Martino, A., Ricozzi, C., et al. (2020) · Biomedicines · doi:10.3390/biomedicines9010003 · Cited by 97
Role of Oxidative Stress in Obese and Nonobese PCOS Patients
Uçkan, K., Demir, H., Turan, K., Sarıkaya, E., & Demir, C. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/4579831 · Cited by 97
Liu, J., Liu, Y., Chen, C., Chang, W., & Chen, C. O. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0400-y · Cited by 97
Hypoxia in Obesity and Diabetes: Potential Therapeutic Effects of Hyperoxia and Nitrate
Norouzirad, R., González‐Muniesa, P., & Ghasemi, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5350267 · Cited by 99
Dong, Y., Fernandes, C. J., Liu, Y., Wu, Y., Wu, H., Brophy, M. L., Deng, L., Song, K., Wen, A., Wong, S., et al. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116666762 · Cited by 95
Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women
Maturana, M. A., Breda, V., Lhullier, F. L. R., & Spritzer, P. M. (2008) · Metabolism · doi:10.1016/j.metabol.2008.02.012 · Cited by 95
The role of obesity in the pathogenesis of hypertension
Bogaert, Y. E., & Linas, S. L. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph1022 · Cited by 95
NO-Rich Diet for Lifestyle-Related Diseases
Kobayashi, J., Ohtake, K., & Uchida, H. (2015) · Nutrients · doi:10.3390/nu7064911 · Cited by 94
Jang, H.-J., Ridgeway, S. D., & Kim, J. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00434.2013 · Cited by 93
Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus
Hamilton, S. J., Chew, G. T., & Watts, G. F. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.026 · Cited by 101
Nicoll, R., & Henein, M. Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030751 · Cited by 94
Microvascular Changes in the Diabetic Foot
Schramm, J. C., Dinh, T., & Veves, A. (2006) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734606292281 · Cited by 94
Effect of weight loss on coronary circulation and adiponectin levels in obese women
Coppola, A., Marfella, R., Coppola, L., Tagliamonte, E., Fontana, D., Liguori, E., Cirillo, T., Cafiero, M., Natale, S., & Astarita, C. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.087 · Cited by 92
Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction
Kawakami, A., Osaka, M., Tani, M., Azuma, H., Sacks, F. M., Shimokado, K., & Yoshida, M. (2008) · Circulation · doi:10.1161/circulationaha.108.784785 · Cited by 92
RetractedRezazadeh, L., Gargari, B. P., Jafarabadi, M. A., & Alipour, B. (2019) · Nutrition · doi:10.1016/j.nut.2018.12.011 · Cited by 91
Agarwal, A., Banerjee, A., & Banerjee, U. C. (2011) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2010.527823 · Cited by 91
Buscemi, S., Verga, S., Tranchina, M. R., Cottone, S., & Cerasola, G. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02091.x · Cited by 95
Das, D., Shruthi, N. R., Banerjee, A., Jothimani, G., Duttaroy, A. K., & Pathak, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1221438 · Cited by 90
Serum nitric oxide metabolites in subjects with metabolic syndrome
Zahediasl, S., Ghasemi, A., & Azizi, F. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.08.076 · Cited by 90
Does reversal of oxidative stress and inflammation provide vascular protection?
Koh, K. K., Oh, P. C., & Quon, M. J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn354 · Cited by 89
A review of recent advances and current hypotheses on the pathogenesis of acute laminitis
Katz, L. M., & Bailey, S. R. (2012) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.2012.00664.x · Cited by 88
Leptin and mechanisms of endothelial dysfunction and cardiovascular disease
Knudson, J. D., Payne, G. A., Borbouse, L., & Tune, J. D. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0082-2 · Cited by 90
Qin, W., Ren, B., Wang, S., Liang, S., He, B.-Q., Shi, X., Wang, L., Liang, J., & Wu, F. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.07.006 · Cited by 88
the Shinken Database Study Group, Nakamura, M., Yamashita, T., Yajima, J., Oikawa, Y., Sagara, K., Koike, A., Kirigaya, H., Nagashima, K., Sawada, H., et al. (2010) · Hypertension Research · doi:10.1038/hr.2010.126 · Cited by 87
Muris, D. M. J., Houben, A. J. H. M., Schram, M. T., & Stehouwer, C. D. A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9231-7 · Cited by 86
TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction
Sun, J., Pu, Y., Wang, P., Chen, S., Zhao, Y. C., Liu, C., Shang, Q., Zhu, Z., & Liu, D. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-69 · Cited by 87
Song, Y., Cook, N. R., Albert, C. M., Denburgh, M. V., & Manson, J. E. (2009) · Diabetes · doi:10.2337/db09-0087 · Cited by 88
Triglyceride-glucose index associated with the risk of cardiovascular disease: the Kailuan study
Liu, Q., Cui, H., Ma, Y., Han, X., Cao, Z., & Wu, Y. (2021) · Endocrine · doi:10.1007/s12020-021-02862-3 · Cited by 86
Mechanisms of hypertension in the cardiometabolic syndrome
Redón, J., Cífková, R., Laurent, S., Nilsson, P. M., Narkiewicz, K., Erdine, S. E., & Mancia, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831e13e5 · Cited by 86
Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease
Moro, L., Pedone, C., Scarlata, S., Malafarina, V., Fimognari, F. L., & Incalzi, R. A. (2008) · Angiology · doi:10.1177/0003319707306141 · Cited by 86
Potenza, M. A., Marasciulo, F. L., Tarquinio, M., Quon, M. J., & Montagnani, M. (2006) · Diabetes · doi:10.2337/db06-0667 · Cited by 87
Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes
Novak, V., Zhao, P., Manor, B. D., Sejdić, E., Alsop, D. C., Abduljalil, A., Roberson, P. K., Munshi, M. N., & Novák, P. (2011) · Diabetes Care · doi:10.2337/dc11-0969 · Cited by 85
Ayers, K. I., Byrne, L. M., Dematteo, A. C., & Brown, N. J. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.189589 · Cited by 84
Mechanisms of Acute Coronary Syndromes
Gómez-Arbeláez, D., & López-Jaramillo, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1307806 · Cited by 87
Liu, J., Jahn, L. A., Fowler, D. E., Barrett, E. J., Cao, W., & Liu, Z. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1174 · Cited by 83
Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs
Koh, K. K., Quon, M. J., Han, S. H., Lee, Y., Kim, S., Koh, Y., & Shin, E. K. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.11.017 · Cited by 82
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou, M., Lambadiari, V., Roden, M., & Dimitriadis, G. D. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnae032 · Cited by 90
Akt: A Potential Drug Target for Metabolic Syndrome
Miao, R., Fang, X., Wei, J., Wu, H., Wang, X., & Tian, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.822333 · Cited by 90
Vincent, H. K., Bourguignon, C. M., WELTMAN, A. L., Vincent, K. R., Barrett, E. J., Innes, K. E., & Taylor, A. G. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.022 · Cited by 83
Effects of insulin resistance on endothelial progenitor cells and vascular repair
Cubbon, R. M., Kahn, M., & Wheatcroft, S. B. (2009) · Clinical Science · doi:10.1042/cs20080263 · Cited by 81
Theilade, S., Lyngbæk, S., Hansen, T. W., Eugen‐Olsen, J., Fenger, M., Rossing, P. R., & Jeppesen, J. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12269 · Cited by 80
Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction
Han, S. H., Quon, M. J., & Koh, K. K. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328012b627 · Cited by 80
Alexandru, N., Bădilă, E., Weiss, E., Cochior, D., Stępień, E. Ł., & Georgescu, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.038 · Cited by 79
Liu, Z., & Cao, W. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009787582397 · Cited by 80
GLUCOSE, INSULIN, DIABETES AND MECHANISMS OF ARTERIAL DYSFUNCTION
Cameron, J. D., & Cruickshank, J. K. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04659.x · Cited by 79
Localized RhoA GTPase activity regulates dynamics of endothelial monolayer integrity
Szulcek, R., Beckers, C., Hodzic, J., de Wit, J., Chen, Z., Grob, T., Musters, R. J. P., Minshall, R. D., van Hinsbergh, V. W. M., & Amerongen, G. P. V. N. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt075 · Cited by 79
The Role of Leukocytes in Diabetic Cardiomyopathy
Bajpai, A., & Tilley, D. G. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01547 · Cited by 80
Reappraisal of Adipose Tissue Inflammation in Obesity
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_10 · Cited by 86
Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis
Durante, A., Peretto, G., Laricchia, A., Ancona, F., Spartera, M., Mangieri, A., & Cianflone, D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436467 · Cited by 78
Su, H., Sun, X., Ma, H., Zhang, H., Yu, Q., Huang, C., Wang, X., Luan, R., Jia, G., Wang, H., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00221.2007 · Cited by 78
Mechanisms of Coronary Dysfunction in Obesity and Insulin Resistance
Knudson, J. D., Dinçer, Ü. D., Bratz, I. N., Sturek, M. S., Dick, G. M., & Tune, J. D. (2007) · Microcirculation · doi:10.1080/10739680701282887 · Cited by 78
Endothelial Function in Pre-diabetes, Diabetes and Diabetic Cardiomyopathy: A Review
Ciccone, M. M. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000364 · Cited by 77
Endothelial Dysfunction in Adults with Obstructive Sleep Apnea
(2011) · Advances in cardiology · doi:10.1159/000325108 · Cited by 76
Oda, E., & Kawai, R. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.2670 · Cited by 77
Faeh, D., William, J., Yerly, P., Paccaud, F. M., & Bovet, P. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-32 · Cited by 77
Metabolic syndrome—From human organ disease to laminar failure in equids
Geor, R. J., & Frank, N. (2008) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2008.11.012 · Cited by 77
Arginase inhibition alleviates hypertension in the metabolic syndrome
El‐Bassossy, H. M., El‐Fawal, R., Fahmy, A., & Watson, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12144 · Cited by 75
Nacci, C., Tarquinio, M., Benedictis, L. D., Mauro, A., Zigrino, A., Carratù, M. R., Quon, M. J., & Montagnani, M. (2008) · Endocrinology · doi:10.1210/en.2008-1069 · Cited by 75
Jensterle, M., Šebeštjen, M., Janež, A., Preželj, J., Kocjan, T., Keber, I., & Pfeifer, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0507 · Cited by 76
Wang, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01528.x · Cited by 75
Circulating Insulin-Like Growth Factor Binding Protein-1 and the Risk of Pancreatic Cancer
Wolpin, B. M., Michaud, D. S., Giovannucci, E. L., Schernhammer, E. S., Stampfer, M. J., Manson, J. E., Cochrane, B. B., Rohan, T. E., Ma, J., Pollak, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0373 · Cited by 74
Insulin resistance, lipotoxicity and endothelial dysfunction
Imrie, H., Abbas, A., & Kearney, M. T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.025 · Cited by 74
Chadderdon, S. M., Belcik, J. T., Bader, L., Kirigiti, M. A., Peters, D., Kievit, P., Grove, K. L., & Lindner, J. R. (2013) · Circulation · doi:10.1161/circulationaha.113.003645 · Cited by 74
Mahmoud, A. M., Szczurek, M. R., Blackburn, B. K., Mey, J. T., Chen, Z., Robinson, A. T., Bian, J.-T., Unterman, T. G., Minshall, R. D., Brown, M. D., et al. (2016) · Physiological Reports · doi:10.14814/phy2.12895 · Cited by 75
Sakboonyarat, B., Rangsin, R., Kantiwong, A., & Mungthin, M. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4417-7 · Cited by 74
Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction
Yunoki, K., Nakamura, K., Miyoshi, T., Enko, K., Kohno, K., Morita, H., KUSANO, K. F., & Ito, H. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.019 · Cited by 74
Uric Acid in Hypertension and Renal Disease: The Chicken or the Egg
Kanbay, M., Solak, Y., Doğan, E., Lanaspa, M. A., & Covic, A. C. (2010) · Blood Purification · doi:10.1159/000321074 · Cited by 74
Alteration of nitric oxide-mediated blood flow regulation in diabetes mellitus
Toda, N., Imamura, T., & Okamura, T. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.009 · Cited by 71
The renin-angiotensin system and insulin resistance
Liu, Z. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0007-5 · Cited by 76
Fu, Z., Wu, J., Nesil, T., Li, M. D., Aylor, K. W., & Liu, Z. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2016 · Cited by 74
Obesity and Insulin Resistance in Resistant Hypertension: Implications for the Kidney
Rao, A., Pandya, V., & Whaley‐Connell, A. T. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.12.004 · Cited by 78
Metadata
- Authors
- Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J.
- Affiliations
- National Institutes of Health (US)
- Venue
- Circulation
- Published
- 2006-04-18
- Volume
- 113
- Issue
- 15
- Pages
- 1888-1904
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2126412451
- Cited by
- 1,652
- References
- 186
- Citations by year
- 2026: 68 · 2025: 80 · 2024: 61 · 2023: 55 · 2022: 67 · 2021: 71 · 2020: 67 · 2019: 64 · 2018: 76 · 2017: 70 · 2016: 76 · 2015: 99 · 2014: 96 · 2013: 119 · 2012: 108
- FWCI
- 61.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- National Center for Complementary and Alternative Medicine
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- insulin resistance, endothelial dysfunction, nitric oxide, endothelin-1, phosphatidylinositol 3-kinase signaling, glucose uptake, skeletal muscle blood flow, type 2 diabetes, obesity, cardiovascular disease, inflammation, bidirectional relationship
- MeSH terms
- Animals, Disease Models, Animal, Endothelium, Vascular, Glucose, Hemodynamics, Homeostasis, Humans, Insulin, Insulin Resistance, Signal Transduction, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review